☰
We are very grateful to the NC3Rs for strategic funding for our project to identify robust reagents to study key targets of interest to research groups based across the Midlands. For more information, please see their Website.
Learn More
The OGA partnership is supported by funding from the MRC-NIHR Better Methods, Better Research panel for our project to drive better standards in antibody choice and use. For more information, please see NIHR Leicester BRC announcement.
Learn More
Our lab team is supported by the Leicester Institute for Precision Health and an MRC Impact Accelerator Award to identify robust antibodies that can measure proteins predicting treatment responses in ILD patients. This work aims to improve diagnosis and treatment of ILD. This work has the potential to improve how patients with IDL are disgnosed and treated. For more information, contact hsv6@leicester.ac.uk.
Contact Us